A European partner in Life Science

Our vision is to improve people's lives by being a leading, value-adding partner in Life Science

Year-end Report Q4-2025
Graph

Share price

2026-02-04

Press Releases

  • Quote

    Continued positive margin development

    Fredrik Dalborg, President and CEO

    The EBITA margin continues to develop positively and profits are growing. The strong cash flow means that our ambition to reduce the debt level has been achieved and exceeded. AddLife enters 2026 with improved profitability and a strong balance sheet. The increased acquisition activity has been initiated.

    comments by the ceo
    NY Q4 Fredrik Dalborg VD Ord 2025
  • Biolin Scientific - Expertise in advanced surface and interface analysis

    With 30 years of experience, a robust global footprint, and a focus on research-driven innovation within advanced surface and interface analysis, Biolin Scientific stands out as a key enabler of scientific progress. Its solutions empower academic and industrial researchers to achieve outstanding results within academic innovation and high-impact R&D.

    Watch the video here:

    Watch movie
    Biolin Scientific Q4 2025
  • AddLife acquires Opitek International

    AddLife has acquired Opitek International ApS (“Opitek”), a manufacturer specializing in patient positioning. Opitek, a Danish MedTech company renowned for its specialized solutions in safe and efficient patient positioning before and during surgery that address both staff ergonomics and patient safety. The company will become part of Mediplast, a company within AddLife’s Business Area Medtech and has yearly sales of approximately 8 million DKK.

    To opitek international
    Opitek
  • AddLife acquires Pharmacold

    AddLife acquires Pharmacold A/S, a leading Danish specialist in refrigeration technology and service for the pharmaceutical and healthcare sectors. Pharmacold will become a subsidiary of Holm & Halby, a company within AddLife’s business Area Labtech. Pharmacold delivers advanced, customised solutions for temperature-controlled storage, including installation, service, and support of refrigeration and freezer systems, climate control systems, and mobile low-temperature units. Pharmacold, with a current revenue of EUR 3.4 million, operates primarily in Denmark.

    To Pharmacold
    IMG 0822 Mp 1000
  • HC21 - The caring company

    Healthcare 21 was established twenty-two years ago as a 21st-century solution for healthcare products and services. From the very beginning, ‘the caring company’ was born, and the culture has always been fundamental to the HC21 business with passionate, dedicated, and committed teams who deliver the best products and services across 15 different therapeutic areas in the Irish market. 

    Healthcare 21 has been a great addition to the AddLife family. The teams at HC21 have truly embraced the AddLife culture, delivering on our important metrics.

    Watch the video here:

    Watch movie
    HC21 Cover Web

Our business areas

Medtech

MEDTECH

In the Medtech business area, the subsidiaries offer products and services in medical technology, as well as assistive equipment and digital solutions for use in home care. Medtech has two business units - Hospital and Homecare. The Medtech offering mainly focuses on publicly funded healthcare, home care and social care in Europe.

Read more
Labtech

LABTECH

The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. The business area consists of two business units: Biomedical and Research and Diagnostics. The most important customer groups are hospital laboratories, academic research and pharmaceutical companies in Europe.

Read more

Join the AddLife group

Do you have a Life Science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary, you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.

Acquisitions

News from our subsidiaries

20 January 2026 | Hepro
Hepro satsar internationellt

Den första etableringen sker i Sverige, där Zafe Care Systems, som i likhet med Hepro, tillhör koncernen AddLife AB, byter namn till Hepro Care AB, och blir Hepros operativa enhet i Sverige

02 December 2025 | Hepro
New agreement with Værnesregionen

Værnesregionen, covering 35 municipalities, chooses Hepro AS to deliver welfare-technology equipment to people living at home.

27 November 2025 | Fischer Medical
The power of simplicity and purpose

Being a lean team, we focus on things that create value to us, the patients, and the healthcare professionals.

See all news

Sustainability for AddLife

Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in Life Science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.

Adobestock 300716540